Photodynamic therapy in dermatology

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

The review focused on the development of utilizing photodynamic therapy (PDT) in skin diseases in Taiwan is presented. PDT uses a sensitizer, light and molecular oxygen to selectively kill cells. The use of 5-aminolevulinic acid (ALA) as photosensitizing prodrug to treat patients with basal cell carcinoma, Bowen's disease and actinic keratosis was begun in 1998. PDT could also improve wound healing in patients with chronic infected wounds.

Original languageEnglish
Title of host publicationSecond Asian and Pacific Rim Symposium on Biophotonics - Proceedings, APBP 2004
Pages70-71
Number of pages2
Publication statusPublished - 2004
EventSecond Asian and Pacific Rim Symposium on Biophotonics, APBP 2004 - Taipei, Taiwan
Duration: 2004 Dec 152004 Dec 17

Publication series

NameSecond Asian and Pacific Rim Symposium on Biophotonics - Proceedings, APBP 2004

Other

OtherSecond Asian and Pacific Rim Symposium on Biophotonics, APBP 2004
CountryTaiwan
CityTaipei
Period04-12-1504-12-17

All Science Journal Classification (ASJC) codes

  • Engineering(all)

Fingerprint Dive into the research topics of 'Photodynamic therapy in dermatology'. Together they form a unique fingerprint.

Cite this